Teaching patients to monitor their risk factors retards the progression of vascular complications in high‐risk patients with Type 2 diabetes mellitus—a randomized prospective study
- 16 May 2002
- journal article
- clinical trial
- Published by Wiley in Diabetic Medicine
- Vol. 19 (5) , 385-392
- https://doi.org/10.1046/j.1464-5491.2002.00701.x
Abstract
Aims Intensive management of risk parameters in diabetic patients may retard the progression of both micro‐ and macrovascular complications. Intensified care requires expert staff and is expensive. The aim of the present study was to examine whether sharing the therapeutic responsibility with the patients will improve the outcome. Methods A randomized prospective study of 165 patients with diabetes mellitus Type 2, hypertension (> 140/90 mmHg) and hyperlipidaemia (LDL‐C > 120 mg/dl). Patients were randomly allocated to standard annual consultation (SC) or to a patient participation programme (PP). The medical care for both groups was administered by primary care physicians, who were unaware of the nature of the intervention. Results At 4 years the mean blood pressure was 148/88 (± 6.1/1.7) mmHg in the SC patients vs. 142/84 (± 5.8/1.8) mmHg in the PP group (P = 0.02). The mean LDL‐C was 124 ± 8 and 114 ± 6 mg/dl (P = 0.01) and the mean HbA1c was 8.9 ± 1.2% and 8.2 ± 1.5% (P = 0.04) in the SC and PP groups, respectively. The average annual fall in estimated glomerular filtration rate was 3.5 ml/min per year in the SC group vs. 2.25 in the PP group (P < 0.05). Albumin/creatinine ratio > 300 mg/g developed in four SC patients vs. none of the PP patients. There was a total of 36 cardiovascular events in the SC group vs. 23 in the PP group (P = 0.04). All patients in the PP group received ACE inhibitors (or AII blockers) and statins vs. 52% and 43%, respectively, in the SC group. Glucose‐lowering regimens were similar. Conclusions Well‐informed and motivated patients were more insistent to reach and maintain target values of the main risk factors of diabetic complications. The differences between the PP and SC groups were of the same order of magnitude as those between intensive and standard care groups in other studies albeit with, comparatively, a very modest cost.Keywords
This publication has 36 references indexed in Scilit:
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyPublished by Elsevier ,2002
- Diabetes guidelines: A summary and comparison of the recommendations of the american diabetes association, veterans health administration, and american association of clinical endocrinologistsClinical Therapeutics, 2000
- Task force VIBlood Pressure Monitoring, 1999
- Effects of intensified antihypertensive treatment in diabetic nephropathyJournal Of Hypertension, 1999
- Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic HypertensionNew England Journal of Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- Trends in Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction and Effect of Diabetes on Survival: The Minnesota Heart SurveyDiabetes Care, 1991
- Prognosis in diabetic nephropathy.BMJ, 1989
- An improved colour reagent for the determination of blood glucose by the oxidase systemThe Analyst, 1972